My comment about destroying wealth was not specific to EMV. It was in relation to medical oem’s where an equipment may be fantastic but it’s not good business.
There is a common excuse that institutions can’t invest in this or that. It’s a ruse. There are thousands of professional investment firms/funds that can invest but don’t. So best we don’t make excuses.
Ann: Clinical Trial Stage 1 Enrolment Completed, page-19
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.96 |
Change
-0.045(2.25%) |
Mkt cap ! $171.7M | |||
| Open | High | Low | Value | Volume |
| $2.01 | $2.01 | $1.96 | $19.85K | 9.932K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4159 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.99 | 1979 | 3 |
View Market Depth
| Last trade - 12.50pm 18/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |